Asthma Flashcards
Asthma
➢Chronic inflammatory disorder of the airways characterized by increase responsiveness of the ___________ tree to a variety of stimuli
➢This disorder causes recurrent episodes of
● _______, Breathlessness, Chest tightness, Cough (night and early a.m. ), Variable airflow obstruction that is REVERSIBLE
●Tachypnea, Prolonged _______ phase, Fatigue
- tracheobronchial
- wheezing
- expiratory
Pathophysiology of Asthma
➢Airway __________ and inflammation
➢Mediators include: all have been implicated as histologic mediators
➢ Eosinophils, mast cells, neutrophils, ________, basophils,T lymphs
➢Other probable mediators of acute __________
include: cytokines, interleukins, ________ acid metabolites (leukotrienes and prostaglandins),kinins, histamine, adenosine, and PAF
- hyper-responsiveness
- macrophages
- bronchoconstriction
- arachidonic
Pathophysiology of Asthma
➢Asthma creates airways that are:
●inflamed, ________, hypersensitive to irritant stimuli
➢ The degree of airway responsiveness and bronchoconstriction parallels the extent of __________
- edematous
* inflammation
Asthma: Alterations in PFTs/Lung Volumes
- Decreased ______
- extent of decrease reflects severity of ______ obstuction
- FEV1
* expiratory
Asthma: Blood Gas Alterations
- In mild to moderate asthma FEV1 >50% predicted – PaO2 and PaCO2 _____
- In fact, PaCO2 often decreased as a result of ______ (neural reflex to bronchoconstriction)
- With severe asthma (FEV1 less than 25%) - PaO2 may be less than 60mmHg and ______ may develop
- CXR = _______ of the lungs
- normal
- hyperventilation
- hypercarbia
- hyperinflation
Pharmacologic Management: Prophylactic Approach
Treat Underlying Inflammation
*Inhaled Corticosteroids: Decreases ______ and hyper-responsiveness
*Cromolyn
*Leukotriene _________
*Methylxanthines-phosphodiesterase inhibitors
- bronchial mucosal inflammation
* inhibitors
Pharmacologic Management: Rescue Approach - Bronchodilators
*Beta-2 Adrenergic Agonists – albuterol, ________
- B-2 receptor activation of adenylate cyclase with increased _____
concentrations & bronchodilation
- SNS side effects: tachycardia, dysrhythmias, _____ shifts
- terbutaline
- cAMP
- potassium
Pharmacologic Management: Rescue Approach - Bronchodilators (con’t)
- Anticholinergic Drugs – ________
- Block muscarinic receptors = _______
- Less effective than B-2 in asthmatics
- ipratropium
* bronchodilation
Pre-Induction
- Assess Breath Sounds
- ____ before and after bronchodilator therapy for major elective operations (especially FEV1)
- _______ should be >70%-80% expected or personal best prior to surgery
- FEV1/FVC less than ____% = mod/severe asthma
- CXR, ABG
- PFTs
- FEV1/FVC
- 50%
Pre-Induction (con’t)
➢________ – good choice (anxiety can precipitate bronchospasm)
➢Opioids: consider the respiratory depressant effect
➢H-2 antagonist: _________ receptors responsible for bronchoconstriction
➢Continue current asthma ________ into peri-op period
- benzodiazipines
- unopposed H-1
- medications
Peri-operative Prophylaxis of Bronchoconstriction
➢Pre-operative bronchodilators – _______ before induction
➢Pre-operative steroids
1. Inhaled – start ___ hours pre-op
2. IV - _________ 100mg Q 8 hrs on day of surgery if FEV1 less than 80% predicted or at risk for HPA suppression
- albuterol
- 48
- hydrocortisone
Asthma and Anesthesia
Anesthesia-
➢Consider regional techniques
➢GA should be designed to
- depress ______ reflexes, avoid hyperactivity, avoid
bronchoconstriction, avoid _______ release
- airway
* histamine
Induction and Maintenance in the Asthmatic Patient:
➢Blunt airway reflexes and bronchoconstriction response during airway instrumentation
- Regional Anesthesia a good option, IV induction: propofol & ______
best, avoid drug preparations with ______, IV opioids
●Consider _______ 1.5 mg/kg IV or intratracheal (LTA)
- ketamine
- metabisulfites
- lidocaine
Induction and Maintenance in the Asthmatic Patient
•High concentration of volatile agent ______ for bronchodilation and bronchial reflex inhibition (need a strong CV system)
•Sevoflurane and Halothane less _______ – less coughing to trigger bronchospasm
- > 1.5 MAC
* pungent
Induction and Maintenance in the Asthmatic Patient
➢Avoid NDMR that release ______
- _______, mivacurium, metacurium, d-tubo
➢Anticholinesterase drugs
- _______ O.K. if given with anticholinergic (glycopyrulate)
- histamine
- atracurium
- neostigmine